Thursday, April 30, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Contrarian

What’s Missing in Vaccine Discourse

It’s modern-day opium for the masses.

Daily Remedy by Daily Remedy
December 18, 2023
in Contrarian
0
What's Missing in Vaccine Discourse

Getty Images

Health policy today seems hell bent on reviving the days of yellow journalism, where sensationalization was the calling card for the masses.

Every media outlet, political candidate seeking office, or purported subject matter expert has a take on vaccines. Usually they’re the most extreme takes. Those garner the most attention.

The problem, however, isn’t the lack of a more centrist, pragmatic approach to vaccines. It’s more fundamental. We lack a basic understanding of vaccine risk and benefits. As a result, we’re unable to contextualize the value of vaccines relative to their downside. In our ignorance, we grow irate. To reset the escalatory rhetoric, we need to relearn the nuts and bolts of vaccines.

Vaccines have always been a fiercely contested topic. Each argument, no matter how eloquent, revolves largely around individual rights versus collective benefits. Those who champion individual rights focus on the risk of receiving a vaccine injection. Those who stress collective safety focus on the risk of being infected by a disease the vaccine intends to protect against.

At face value, arguments on both sides are justifiable. This is why the debates never end. Nobody’s truly wrong in the absolute sense. Each vaccine injection carries an individual risk and vaccines in aggregate provide a collective benefit. But the collective benefit is determined by the aggregate behavior, which is the sum of all the decisions and actions of individuals that lead them to receive a vaccine.

The more who receive it, the greater the benefit, which varies based on the percentage of a population that get vaccinated, while the risk per vaccine is fixed per individual. The issue comes down to a balance between the varying benefit to the community against the fixed individual risk of vaccines. This can be visualized as a ratio which increases or decreases based on the percentage of a population that receive the vaccine.

Simply put, those who are against vaccines focus on the fixed risk, while those who are for vaccines focus on the collective benefits.

That’s the crux of the argument. But you wouldn’t be able to tell based on what you hear. Most of the debate centers on individual scenarios or anecdotal case studies. But the benefits and risks cannot be assessed at an individual level alone. Yet that’s where we see most of the back-and-forth. More problematically, those who support vaccines fail to convey the collective benefit to those who may be more skeptical by reframing the argument in collective terms, at a population level.

It would be more instructive if we contextualize the discussion on vaccines around individual risk and collective benefit. Recognize that risk to benefit cannot be compared one-to-one nor at a population level alone. Rather, it’s a difficult-to-quantify balance of individual risk to collective benefit. The complexity of the matter makes it difficult to distill into a bullet point argument – regardless of the side you’re on – because the points of contention don’t really match up.

Individual risk doesn’t directly compare to collective benefit. Collective value to the masses doesn’t really equate to an individual’s risk.

But we don’t want to see it that way. We want to compare apples to apples and oranges to oranges: individual risk to individual benefit, or collective risk to collective benefit. Unfortunately, vaccines don’t work that way. So we’re stuck with incomplete, not-quite-wrong, but not-quite-right, arguments. And of course, like children arguing until they forget what they’re arguing about, the rhetoric gets lost in the heat of the exchange.

Soon winning the argument becomes the only goal, leading both sides to argue for inherently incomplete stances taking one extreme side or another that instead should be contextualized as a balance between two perspectives: individual risk and collective benefits.

This is why we argue so passionately about vaccines. Each side simply focuses on their own point of view without considering the context of the argument. Behavioral economists call this denominator neglect: situations in which people focus only on the most overt aspects of an argument but cannot consider the full context of the issue. Denominator neglect is largely a problem of perception. It can be corrected if the argument is seen as a balance among multiple perspectives and visualized through a structured framework.

But instead, we find simplified talking points dominating healthcare policies and decisions. So that’s how we come to think. Eventually, the talking points are parroted enough to where they’re ingrained in the minds of the public, whether or not correct.

People have a tendency to look for what’s familiar in the news they consume, particularly for healthcare topics. This is well known among media outlets that cover health policy and the politicians who legislate over it. That’s why we see overly simplified arguments repeated ad nauseam until what’s familiar becomes what’s generally understood by the listening audience.

It’s yellow journalism using nothing more than the veneer of science to perpetuate an inherently incomplete, dumbed-down argument about a complex topic. It’s modern-day opium for the masses.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.

    Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.

    0 shares
    Share 0 Tweet 0
  • Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape

    0 shares
    Share 0 Tweet 0
  • State Regulators and the Federal Data Gap: How MedPricer Fills What CMS Leaves Incomplete

    0 shares
    Share 0 Tweet 0
  • Chronic Care Toolbox

    1 shares
    Share 0 Tweet 0
  • The Importance of Access Control in the Workplace

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy